Lupin receives FDA approval for tablets to boost wakefulness

Baltimore-based Lupin Pharmaceuticals earned approval from the Food and Drug Administration for its armodafinil tablets.

Advertisement

According to a news release, the tablets are intended to improve wakefulness in adults with excessive sleepiness caused by various sleep disorders.

Armodafinil tablets are the generic equivalent of Cephalon’s Nuvigil tablets.

More articles on supply chain:

4 threats to the US blood supply
FDA approves Lanett’s muscle relaxant drug: 3 things to know
Addiction centers pay more than $700k to resolve allegations of improper prescribing

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.